AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUL 306 min read$EMN

EASTMAN CHEMICAL CO (EMN): Results of Operations and Financial Condition

EASTMAN CHEMICAL CO (EMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.01 2 ex99_0120260630cctables.htm EX-99.01 Q2 2026 EARNINGS RELEASE Document Exhibit 99.01 Eastman Announces Second-Quarter 2026 Financial Results KINGSPORT, Tenn., July 30, 2026 – Eastman Chemical Company (NYSE:EMN) announced its second-quarter 2026 financial results. • Del

Original reporting
SEC EDGAR 8-K
Published Jul 30, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$EMN
Neutral
medium confidence
Mentioned
$EMN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EMNNeutralMed
01

Why it matters

Key disclosed items for trading are sequential adjusted EBIT margin improvement (350 bps), progress toward $125M to $150M cost savings, and a revised expectation that operating cash flow will approach $900M due to inflationary pressure on accounts receivable.

02

Market read

This is a primary earnings release filing with decision-relevant numbers and a specific cash-flow outlook change, which can reprice expectations for 2026 earnings quality and capital allocation.

03

What to watch

Receivables inflation pressure is explicitly called out; traders may underweight how working-capital timing could affect free cash flow and buyback capacity even if earnings improve.

Relevance 7/10Novelty 8/10Timing: after-hours filing on July 30, 2026, with Q2 results and 2026 cash outlook

Background

The 8-K includes Eastman’s Q2 2026 earnings release (Exhibit 99.01) and Item 2.02 results of operations and financial condition.

Company-level read

Ticker impact

$EMNNeutralMedium confidence
Context

Eastman reported Q2 2026 results and updated full-year 2026 cash outlook, including operating cash flow expected to approach $900M.

Expected impact

Moderate two-sided reaction risk, with upside support from EBIT margin improvement and cost-savings progress, offset by weaker operating cash flow expectations from receivables pressure.

Evidence & confidence

The filing discloses multiple decision-relevant datapoints: sequential adjusted EBIT margin improvement, cost-savings target progress, and a specific operating cash flow expectation change tied to inflation and accounts receivable pressure. However, the excerpt does not include the full quantitative guidance range or consensus context, limiting precision on magnitude.

Market effects

Sector

Signals resilience in specialty chemicals pricing/spreads amid Middle East supply-chain disruption, but highlights working-capital sensitivity to inflation.

Regional

Limited direct regional read-through beyond U.S.-based integrated asset utilization and receivables pressure.

Global

Middle East conflict is cited as a driver of spreads and pricing, implying continued volatility in chemical intermediates supply chains.

Counterpoint

What could challenge this read

Margin and spread expansion may be partially cyclical and could fade if Middle East-driven supply disruptions normalize, making the cash-flow caution more important than the EBIT momentum.

Key entities

  • company
    Eastman Chemical Company

    NYSE-listed chemical manufacturer reporting Q2 2026 financial results and providing 2026 outlook commentary, including operating cash flow expectations.

  • executive
    Mark Costa

    Board Chair and CEO quoted on Q2 performance, margin drivers, Middle East impact, and cash flow outlook.

Read at source← All news

Related articles

AUG 7
$EMNMed

Moody’s shifts Eastman Chemical outlook on cash flow concerns

Moody’s Ratings changed Eastman Chemical’s outlook to negative from stable, while keeping its Baa2 issuer and senior unsecured ratings and Prime-2 commercial paper rating. The move cites weaker-than-expected operating cash flow for 2026, lower expected cash flow near $900 million, and higher debt leverage versus the downgrade trigger. Eastman expects 2026 EBITDA about $1.5 billion.

investing.com4 min
JUL 31
$EMNMed

Eastman Chemical: Q2 Earnings Snapshot

Eastman Chemical Co. (EMN) reported Q2 profit of $183 million, or $1.59 per share. Adjusted earnings were $1.97 per share versus a Zacks average estimate of $1.80. Revenue was $2.51 billion, above the $2.37 billion forecast from five Zacks analysts.

local3news.com2 min
JUL 10
$EMNMed

Euro Manganese Inc.: Euro Manganese Strengthens Financial Position with Conditional Debt-To-Royalty Conversion on Chvaletice Manganese Project

Euro Manganese Inc. (TSXV: EMN, ASX: EMN) said it amended its Orion facility. Under a July 9, 2026 convertible loan and royalty agreement, EMN’s outstanding loan and accrued interest will automatically convert into a royalty on its Chvaletice Manganese Project if a fundraising condition is met. The conversion would fully discharge repayment. Royalty rate is 2.29-2.46% of project revenues.

finanznachrichten.de4 min
JUN 4
$RIOMed

Asian Markets Track Wall Street Lower

Asian markets mostly fell Thursday after Wall Street closed lower, with crude oil rising on renewed Middle East attacks and delays to a U.S.-Iran peace MoU. U.S. Central Command cited missile/drone defeats and strikes on Qeshm Island. Australia’s S&P/ASX 200 fell 1.41% to 8,662.20; Japan’s Nikkei 225 dropped 1.90% near 67,100. WTI July rose to $96.07 (+2.46%).

finanznachrichten.de6 min
AUG 8
$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

yahoo.com6 min
AUG 8
$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

yahoo.com6 min